0001179110-18-013076.txt : 20181121 0001179110-18-013076.hdr.sgml : 20181121 20181121161206 ACCESSION NUMBER: 0001179110-18-013076 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181119 FILED AS OF DATE: 20181121 DATE AS OF CHANGE: 20181121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Knowlton Orsula V CENTRAL INDEX KEY: 0001685832 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37888 FILM NUMBER: 181198334 MAIL ADDRESS: STREET 1: 228 STRAWBRIDGE DRIVE STREET 2: SUITE 100 CITY: MOORESTOWN STATE: NJ ZIP: 08057 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tabula Rasa HealthCare, Inc. CENTRAL INDEX KEY: 0001651561 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 465726437 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 228 STRAWBRIDGE DRIVE STREET 2: SUITE 100 CITY: MOORESTOWN STATE: NJ ZIP: 08057 BUSINESS PHONE: 866-648-2767 MAIL ADDRESS: STREET 1: 228 STRAWBRIDGE DRIVE STREET 2: SUITE 100 CITY: MOORESTOWN STATE: NJ ZIP: 08057 4 1 edgar.xml FORM 4 - X0306 4 2018-11-19 0 0001651561 Tabula Rasa HealthCare, Inc. TRHC 0001685832 Knowlton Orsula V 228 STRAWBRIDGE DRIVE SUITE 100 MOORESTOWN NJ 08057 1 1 0 0 President Common Stock 2018-11-19 4 S 0 1066 59.71 D 838575 D Common Stock 2018-11-19 4 S 0 1636 60.76 D 836939 D Common Stock 2018-11-19 4 S 0 3598 61.67 D 833341 D Common Stock 2018-11-19 4 S 0 800 62.63 D 832541 D Common Stock 2018-11-19 4 S 0 400 64.28 D 832141 D Common Stock 2018-11-19 4 S 0 500 65.32 D 831641 D Common Stock 847109 I Held by spouse. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $59.31 to $60.30, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnotes (2), (3), (4), (5), (6) and (7) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $60.31 to $61.25, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $61.32 to $62.07, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $62.29 to $62.84, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $63.86 to $64.53, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.94, inclusive. The sales aggregated in Row 5 of Table I are not matchable under Section 16(b) of the Securities Exchange Act of 1934 against purchases at lower prices by Dr. Calvin H. Knowlton on November 12, 2018 because such purchases were previously matched with sales on September 7, 2018 at higher sales prices, and Dr. Calvin H. Knowlton has already paid to Tabula Rasa Healthcare, Inc. the full amount of profit realized in connection with the previous short-swing transactions. Thus, no further disgorgement under Section 16(b) would result from the transactions disclosed herein. The sales aggregated in Row 6 of Table I are not matchable under Section 16(b) of the Securities Exchange Act of 1934 against purchases at lower prices by Dr. Calvin H. Knowlton on November 12, 2018 because such purchases were previously matched with sales on September 7, 2018 at higher sales prices, and Dr. Calvin H. Knowlton has already paid to Tabula Rasa Healthcare, Inc. the full amount of profit realized in connection with the previous short-swing transactions. Thus, no further disgorgement under Section 16(b) would result from the transactions disclosed herein. /s/ Brian W. Adams, by Power of Attorney 2018-11-21